- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Algotec introduces ImagiNet Lite
Low-volume imaging facilities are the intended beneficiaries of Algotec's Web-based PACS product called ImagiNet Lite. The product, launched at SCAR, is designed for freestanding clinics, small centers, and hospitals that perform fewer than 75,000
Low-volume imaging facilities are the intended beneficiaries of Algotec's Web-based PACS product called ImagiNet Lite. The product, launched at SCAR, is designed for freestanding clinics, small centers, and hospitals that perform fewer than 75,000 procedures annually. With a sticker price of under $100,000, the new product is intended to appeal to smaller practices with limited budgets, according to the company. The product is based on the same software as Algotec's standard ImagiNet PACS. It is scalable to grow with an institution as imaging volume increases, and is compatible with other information systems, such as patient scheduling and radiology information systems.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
